NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model

Breast Cancer Research

Volumn 13, Issue 4, 2011, Pages

  Connelly, Linda ^a,b   Barham, Whitney ^a   Onishko, Halina M ^a   Chen, Lianyi ^a   Sherrill, Taylor P ^c   Zabuawala, Tahera ^d   Ostrowski, Michael C ^d   Blackwell, Timothy S ^a,c,e   Yull, Fiona E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DOXYCYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REVERSE TETRACYCLINE TRANSACTIVATOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; COLONY STIMULATING FACTOR RECEPTOR; CXCL9 CHEMOKINE; CXCL9 PROTEIN, MOUSE; DOXIFLURIDINE; FLOXURIDINE; I KAPPA B KINASE; IKK2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTITUMOR GENE; APOPTOSIS; ARTICLE; BREAST TUMOR; CLINICAL ASSESSMENT; ENZYME ACTIVATION; FLOW CYTOMETRY; LUNG HOMOGENATE; LUNG METASTASIS; MACROPHAGE; MOUSE; NONHUMAN; OPERON; OUTCOME ASSESSMENT; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR REGRESSION; TUMOR SEEDING; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; LUNG; LUNG TUMOR; METABOLISM; METASTASIS; PATHOGENICITY; PATHOLOGY; POLYOMA VIRUS; VEIN; VIROLOGY;

ANIMALS; ANTIGENS, CD11B; CHEMOKINE CXCL9; FEMALE; FLOXURIDINE; I-KAPPA B KINASE; LUNG; LUNG NEOPLASMS; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NF-KAPPA B; PHENOTYPE; POLYOMAVIRUS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RECEPTORS, COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; VEINS;

EID: 80052139985     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2935     Document Type: Article

References (39)

1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444. 10.1038/nature07205, 18650914.
2. Mantovani A. Molecular pathways linking inflammation and cancer. Curr Mol Med 2010, 10:369-373. 10.2174/156652410791316968, 20455855.
3. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260. 10.1146/annurev.immunol.16.1.225, 9597130.
4. Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 2009, 27:693-733. 10.1146/annurev.immunol.021908.132641, 19302050.
5. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540-546. 10.1126/science.3140380, 3140380.
6. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362. 10.1016/j.cell.2008.01.020, 18267068.
7. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683. 10.1146/annurev.immunol.14.1.649, 8717528.
8. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, Blackwell TS. Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol 2007, 178:6504-6513.
9. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE. Inhibition of NF-kappaB activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 2011, 30:1402-1412. 10.1038/onc.2010.521, 21076466.
10. Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE. Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol 2010, 222:73-81. 10.1002/jcp.21922, 2783968, 19746431.
11. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4:71-78. 10.1038/nrc1256, 14708027.
12. Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009, 1796:11-18.
13. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66:605-612. 10.1158/0008-5472.CAN-05-4005, 16423985.
14. Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 2008, 180:2011-2017.
15. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66:1-9. 10.1016/j.critrevonc.2007.07.004, 17913510.
16. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A, Sica A. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006, 107:2112-2122. 10.1182/blood-2005-01-0428, 16269622.
17. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118:285-296. 10.1016/j.cell.2004.07.013, 15294155.
18. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990. 10.1016/j.cell.2005.04.014, 15989949.
19. Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Pluddemann A, Charles K, Gordon S, Balkwill FR. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006, 176:5023-5032.
20. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 2005, 175:1197-1205.
21. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008, 205:1261-1268. 10.1084/jem.20080108, 2413024, 18490490.
22. Martin MD, Fingleton B, Lynch CC, Wells S, McIntyre JO, Piston DW, Matrisian LM. Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth. Clin Exp Metastasis 2008, 25:877-885. 10.1007/s10585-008-9206-y, 2588650, 18787962.
23. Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ, Ostrowski MC, Himes SR, Hume DA. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163. 10.1182/blood-2002-02-0569, 12393599.
24. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71. 10.1038/5007, 9916792.
25. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605. 10.1002/dvg.20335, 17868096.
26. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA 2002, 99:10482-10487. 10.1073/pnas.152238499, 124949, 12145322.
27. Yee KO, Connolly CM, Duquette M, Kazerounian S, Washington R, Lawler J. The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Res Treat 2009, 114:85-96. 10.1007/s10549-008-9992-6, 2631620, 18409060.
28. Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 2003, 278:26480-26487. 10.1074/jbc.M302238200, 12740377.
29. Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev 2006, 25:323-331. 10.1007/s10555-006-9002-6, 1693571, 16983515.
30. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182:4499-4506. 10.4049/jimmunol.0802740, 2810498, 19342621.
31. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969. 10.1038/nri2448, 2724991, 19029990.
32. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003, 171:3128-3135.
33. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008, 181:3733-3739.
34. Walser TC, Ma X, Kundu N, Dorsey R, Goloubeva O, Fulton AM. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model. J Immunother 2007, 30:490-498. 10.1097/CJI.0b013e318031b551, 17589289.
35. Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006, 66:11432-11440. 10.1158/0008-5472.CAN-06-1867, 17145890.
36. Hagemann T, Biswas SK, Lawrence T, Sica A, Lewis CE. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 2009, 113:3139-3146. 10.1182/blood-2008-12-172825, 2869029, 19171876.
37. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51. 10.1016/j.cell.2010.03.014, 20371344.
38. Powell JD, Boodoo S, Horton MR. Identification of the molecular mechanism by which TLR ligation and IFN-gamma synergize to induce MIG. Clin Dev Immunol 2004, 11:77-85. 10.1080/10446670410001670535, 2275409, 15154616.
39. Lin Y, Bai L, Chen W, Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 2010, 14:45-55. 10.1517/14728220903431069, 3043547, 20001209.